All Stories

  1. Effect of tezepelumab on exacerbation-related oral corticosteroid use in NAVIGATOR

    Article • September 2021, European Respiratory Society (ERS)

    Pr Arnaud Bourdin

  2. Impact of COVID-19 on treatments’ dispensations for chronic airways diseases in France

    Article • September 2021, European Respiratory Society (ERS)

    Pr Arnaud Bourdin

  3. Late Breaking Abstract - Severe Asthma Prevalence, Care Pathways, and Health Care Resource Utilization in France

    Article • September 2021, European Respiratory Society (ERS)

    Pr Arnaud Bourdin

  4. The six million dollar man

    Article • ERJ Open Research, October 2020, European Respiratory Society (ERS)

    Pr Arnaud Bourdin

  5. Targeted literature review: burden of disease associated with severe and uncontrolled asthma in France, Germany, Italy, Spain and the UK

    Article • September 2020, European Respiratory Society (ERS)

    Pr Arnaud Bourdin

  6. LAM is another small airway disease: lessons from microCT

    Article • European Respiratory Journal, July 2020, European Respiratory Society (ERS)

    Pr Arnaud Bourdin

  7. How can we minimise the use of regular oral corticosteroids in asthma?

    Article • European Respiratory Review, February 2020, European Respiratory Society (ERS)

    Pr Arnaud Bourdin

  8. Integrating high dose inhaled corticosteroids into oral corticosteroids stewardship

    Article • European Respiratory Journal, January 2020, European Respiratory Society (ERS)

    Pr Arnaud Bourdin, Dr Carey Meredith Suehs

  9. Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma

    Article • Journal of Asthma and Allergy, December 2019, Taylor & Francis

    Pr Arnaud Bourdin

  10. Systematic review and MAIC of OCS reduction with biologic asthma treatments

    Article • September 2019, European Respiratory Society (ERS)

    Pr Arnaud Bourdin

  11. Qualas: Quality of Life and burden in asthma, a comparison between uncontrolled severe asthma and controlled moderate/severe asthma

    Article • September 2019, European Respiratory Society (ERS)

    Pr Arnaud Bourdin

  12. CCSP counterbalances airway epithelial-driven neutrophilic chemotaxis

    Article • European Respiratory Journal, April 2019, European Respiratory Society (ERS)

    Pr Arnaud Bourdin, Dr Carey Meredith Suehs

  13. Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency

    Article • International Journal of Chronic Obstructive Pulmonary Disease, November 2018, Dove Medical Press

    Pr Arnaud Bourdin

  14. Matching-adjusted indirect comparison of benralizumab versus interleukin-5 inhibitors for the treatment of severe asthma: a systematic review

    Article • European Respiratory Journal, October 2018, European Respiratory Society (ERS)

    Pr Arnaud Bourdin

  15. Impact of sacubitril-valsartan combination in patients with chronic heart failure and sleep apnoea syndrome: the ENTRESTO-SAS study design

    Article • ESC Heart Failure, February 2018, Wiley

    Pr Arnaud Bourdin

  16. Comparison of anti-interleukin-5 therapies in patients with severe asthma: global and indirect meta-analyses of randomized placebo-controlled trials

    Article • Clinical & Experimental Allergy, December 2016, Wiley

    Pr Arnaud Bourdin

  17. Future treatment for asthma

    Article • European Respiratory Review, February 2016, European Respiratory Society (ERS)

    Professor Arnaud Bourdin, Pr Arnaud Bourdin

  18. Club cells and CC16: another “smoking gun”? (With potential bullets against COPD)

    Article • European Respiratory Journal, May 2015, European Respiratory Society (ERS)

    Pr Arnaud Bourdin